Miyazaki, Taito
Aoki, Kotaro
Maeda, Tadashi
Komori, Kohji
Yoshizawa, Sadako
Ishii, Yoshikazu
Urita, Yoshihisa
Tateda, Kazuhiro
Funding for this research was provided by:
Otsuka Pharmaceutical Co., Ltd.
Article History
Received: 22 April 2024
Accepted: 29 August 2024
First Online: 17 September 2024
Declarations
:
: The study protocol was approved by the Ethics Committee of the Toho University School of Medicine. Written informed consent was obtained from 38 patients in the previous study (26092_25118, 27021_26092_25118). The secondary use of the isolated bacterial strains was disclosed on the institutional website, and the participants were given the opportunity to opt-out (A23071).
: The authors declare no competing interests.